ArticleNeurobiology of aging2026
Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson's Progression Markers Initiative cohort.
Article in Neurobiology of aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenetic Aging Clocks Associate with Cognitive Status but Not Cognitive Decline: Evidence from the Parkinson's Progression Markers Initiative.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Motor decline is a hallmark of Parkinson's disease (PD) and biological aging, yet the specific relationship between systemic biological aging and neuromotor function remains under-characterized. This study leveraged longitudinal phenotypic and whole-blood DNA methylation data from the Parkinson's Progression Markers Initiative (PPMI) to evaluate associations between seven epigenetic aging measures, spanning first-generation, second-generation (risk-optimized), rate-based, and next-generation deep-learning clocks, and motor impairment. Motor function was assessed using the Movement Disorder Society-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). While cross-sectional analyses yielded limited evidence, longitudinal repeated-measures analyses revealed robust associations between accelerated epigenetic aging and worsening postural and kinetic tremor phenotypes. Associations with gait, rigidity, and bradykinesia were largely non-significant or inversely related in the overall sample. Sex-stratified analyses revealed sexual dimorphism, with males exhibiting a broad, multi-clock phenotype (involving Horvath, PhenoAge, and GrimAge), where accelerated aging was associated with worsening tremor, gait, and rigidity. In contrast, females showed restricted associations, primarily linking the Hannum clock to tremor and global staging. These findings suggest that systemic biological aging is more strongly associated with longitudinal progression of tremor-related phenotypes than with rigidity or bradykinesia, although mechanistic interpretations regarding specific neural circuits remain hypothesis-generating. Accordingly, accelerated epigenetic aging is robustly associated with longitudinal tremor progression in this cohort, particularly in men, suggesting these metrics may serve as valuable biomarkers for monitoring progression and risk stratification in tremor-dominant phenotypes.
Indexed as
Identifiers
41905169What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.